Meet our Advisory Board
Photo credit university of michigan
William (Bill) Brinkerhoff, MS, MBA
Mr. William (Bill) Brinkerhoff, MS, MBA, served as the President of AlphaCore Pharma LLC until his retirement in 2013. Bill co-founded Cerenis Therapeutics in 2005 and served as its Chief Operating Officer until 2011. He was Vice President of Business Development for Esperion Therapeutics Inc. where he successfully negotiated multiple large potential partnering agreements prior to Esperion's acquisition by Pfizer. Before joining Esperion, Bill was Director of Business Development at Sankyo Co., a Tokyo-based pharmaceutical company. While at Sankyo, he was a member of the Senior Negotiating Team that formed the Sankyo/ Parke-Davis joint venture. Bill has over 20 years of commercial and management experience in the pharmaceutical industry and serves on the board of ONL Therapeutics. He received B.S. and M.S. degrees in Industrial and Operations Engineering and an M.B.A. from the University of Michigan.
Photo Credit Pasick Consulting
Robert Pasick, PhD
Dr. Robert Pasick is dedicated to helping individuals and organizations reach their full potential. Since earning his Ph.D. in Clinical Psychology and Public Practice from Harvard University in 1975, Rob has provided leadership development services through teaching, coaching, speaking and writing. He is the President and Founder of Leaders Connect, a leadership development and networking program for executives and entrepreneurs. Included in his past clients are: Ford, Chrysler, Pfizer, Thomson-Reuters, Terumo, Grupo-Antolin, and the University of Michigan. He also is a Adjunct Faculty at the Ross School of Business, University of Michigan. Rob’s clients range from Fortune 500 executives from all over the world, to men and women starting their first businesses or stepping into their first professional careers.
Jack Secrist, PhD
Dr. Jack Secrist is a former CEO of Southern Research, head of their discovery division and recipient of the John A. Montgomery Award. He is a nucleoside chemistry expert and who managed antiviral and anticancer development projects from discovery to market, funded largely by government grants and contracts.
